Albrioza
EU regulator denies approval for Amylyx’s Albrioza, a potential ALS treatment
Anika Sharma
While Amylyx’s ALS drug, known as Albrioza in Europe and Relyvrio in the US, has made significant strides in the ...
Regulatory Update: Amylyx’s ALS drug faces rejection by the European Medicines Agency (EMA)
SG Tylor
Source – Amylyx Pharmaceuticals On June 23, 2023, the European Medicines Agency (EMA) has formally issued a negative opinion regarding ...
